Misplaced Pages

Herbert Kuhl

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
German gynecologist
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (November 2022)
Herbert Kuhl
A photo of Kuhl taken from a 1999 paper
Born1940 (age 84–85)
Aschaffenburg, Germany
NationalityGerman
EducationGoethe University Frankfurt: chemistry and biochemistry (1961–1967); doctorate in biochemistry and pharmacy (1972); postdoctoral qualification in human medicine for the subject of experimental endocrinology (1977)
Occupation(s)Gynecologist; Medical researcher
Years active1970–present
Medical career
ProfessionProfessor, physician
InstitutionsDepartment of Obstetrics and Gynecology, J. W. Goethe University of Frankfurt; Universitäts-Frauenklinik in Frankfurt
ResearchGynecology

Herbert Kuhl is a German gynecologist who has published extensively in the areas of estrogens, progestogens, menopause, hormonal contraception, and menopausal hormone therapy. His works include numerous original and review articles and several books. Kuhl is a member of many medical societies and has received various scientific awards.

Among Kuhl's most widely cited publications is his 2005 literature review in the journal Climacteric, Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. He has published several articles interpreting the findings of the Women's Health Initiative (WHI) study.

Kuhl was born in Aschaffenburg, Germany in 1940. He was educated at the Goethe University Frankfurt from 1961 to 1977. Kuhl first published in 1970. From 1981, he was a professor at the Universitäts-Frauenklinik (University Women's Clinic) of the Goethe University Frankfurt. Until 2013, Kuhl continued to be affiliated with this institution. Since then however, he has listed no affiliation in his publications except that he resides in Aschaffenburg, Germany.

Selected publications

Books

Authored books

Edited books

Book chapters

Journal articles

Reviews

Studies

Theses/dissertations

References

  1. ^ Kuhl H (1999). "Östrogene für den Mann?" [Estrogens for the Man?]. Journal für Menopause . 6 (2): 15–23. ISSN 1025-6873.
  2. ^ Taubert, H.-D.; Heil, H.; Kuhl, H. (1970). "Untersuchungen über die Wirkung von Äthynil-Oestradiol auf die L-Cystin-Aminopeptidosen-Aktivität im Hypothalamus der weiblichen Ratte" [Investigations on the Effect of Ethynil-Oestradiol on L-Cystine-amino-peptidase Activity in the Hypothalamus of Female Rats]. In Kracht, Joachim (ed.). Endokrinologie der Entwicklung und Reifung: 16. Symposion, Ulm, 26.-28. Februar 1970. Symposion der Deutschen Gesellschaft für Endokrinologie. Vol. 16. Berlin/Heidelberg/New York: Springer-Verlag. pp. 288–289. doi:10.1007/978-3-642-80591-2. ISBN 978-3-642-80591-2. OCLC 863921711.
  3. Kuhl, H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 (Suppl 1): 3–63. doi:10.1080/13697130500148875. eISSN 1473-0804. ISSN 1369-7137. PMID 16112947. S2CID 24616324.
  4. "Web of Science". Clarivate. Retrieved 19 August 2022.
  5. ^ Kuhl H (2003). "Die unterschätzte Bedeutung der Gestagene bei der Hormonsubstitution" [The Underestimated Importance of Progestins in Hormone Replacement Therapy]. Journal für Menopause . 10 (3): 6–12. ISSN 1025-6873.
  6. Wiegratz I, Kuhl H (August 2004). "Progestogen therapies: differences in clinical effects?". Trends Endocrinol Metab. 15 (6): 277–85. doi:10.1016/j.tem.2004.06.006. PMID 15358281. S2CID 35891204.
  7. Mueck, A. O.; Kuhl, H.; Braendle, W. (September 2004). "Ergebnisse und Kommentare zu der WHI-Studie mit Estrogen-Monotherapie" [Results of and Comments on the WHI Study with Estrogen Monotherapy]. Geburtshilfe und Frauenheilkunde (in German). 64 (9): 917–922. doi:10.1055/s-2004-821217. eISSN 1438-8804. ISSN 0016-5751. S2CID 71579060.
  8. Kuhl H (September 2004). "Is the elevated breast cancer risk observed in the WHI study an artifact?". Climacteric. 7 (3): 319–22. doi:10.1080/13697130400003337. PMID 15669557.
  9. Kuhl H (May 2005). "Breast cancer risk in the WHI study: the problem of obesity". Maturitas. 51 (1): 83–97. doi:10.1016/j.maturitas.2005.02.018. PMID 15883113.
  10. Kuhl H, Stevenson J (June 2006). "The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results". Gynecol Endocrinol. 22 (6): 303–17. doi:10.1080/09513590600717368. PMID 16785155. S2CID 25260381.
  11. ^ Kuhl, H.; Schneider, H. P. G. (20 February 2013). "Progesterone – promoter or inhibitor of breast cancer". Climacteric. 16 (Suppl 1): 54–68. doi:10.3109/13697137.2013.768806. eISSN 1473-0804. ISSN 1369-7137. PMID 23336704. S2CID 20808536.
  12. Kuhl, Herbert; Wiegratz, Inka (10 April 2017). "Das Post-Finasterid-Syndrom" [Post-finasteride syndrome]. Gynäkologische Endokrinologie (in German). 15 (2): 153–163. doi:10.1007/s10304-017-0126-2. eISSN 1610-2908. ISSN 1610-2894. S2CID 207071180.
  13. Kuhl, H.; Wiegratz, I. (1 February 2021). "Pharmakokinetik und Pharmakodynamik der in der assistierten Reproduktion verwendeten Gestagene" [Pharmacokinetics and pharmacodynamics of progestogens used in assisted reproduction]. Gynäkologische Endokrinologie (in German). 19 (2): 105–117. doi:10.1007/s10304-020-00372-5. eISSN 1610-2908. ISSN 1610-2894. S2CID 231744549.
Categories:
Herbert Kuhl Add topic